These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 21986465

  • 1. Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban.
    Harenberg J, Marx S, Krämer R, Giese C, Weiss C.
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):637-41. PubMed ID: 21986465
    [Abstract] [Full Text] [Related]

  • 2. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S, Morstabilini G, Fattorini A, Galli L, Denti N, D'Angelo A.
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [Abstract] [Full Text] [Related]

  • 3. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C, Menschiek-Lundin A, Wåhlander K, Lindahl TL.
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [Abstract] [Full Text] [Related]

  • 4. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
    Sermon AM, Smith JM, Maclean R, Kitchen S.
    Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
    [Abstract] [Full Text] [Related]

  • 5. Use of INR calibrator plasmas in the routine coagulation laboratory: a study of two thrombolastin reagents.
    Fattorini A, Pattarini E, Viganò S, Crippa L, D'Angelo A.
    Thromb Res; 2012 Sep; 130(3):e158-62. PubMed ID: 22682443
    [Abstract] [Full Text] [Related]

  • 6. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
    McGlasson DL.
    Clin Lab Sci; 2002 Sep; 15(2):91-5. PubMed ID: 12776770
    [Abstract] [Full Text] [Related]

  • 7. The rivaroxaban-adjusted normalized ratio: use of the prothrombin time to monitor the therapeutic effect of rivaroxaban.
    Kim B, Jang S, Lee YJ, Park N, Cho YU, Park CJ.
    Br J Biomed Sci; 2019 Jul; 76(3):122-128. PubMed ID: 30967043
    [Abstract] [Full Text] [Related]

  • 8. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM, Martinoli JL, LeFlem L, Guinet C, Plu-Bureau G, Depasse F, Perzborn E.
    Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
    [Abstract] [Full Text] [Related]

  • 9. Standardization of coagulation tests.
    Opartkiattikul N.
    Southeast Asian J Trop Med Public Health; 1999 Apr; 30 Suppl 3():79-85. PubMed ID: 10926265
    [Abstract] [Full Text] [Related]

  • 10. Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.
    Barrett YC, Wang Z, Frost C, Shenker A.
    Thromb Haemost; 2010 Dec; 104(6):1263-71. PubMed ID: 20978714
    [Abstract] [Full Text] [Related]

  • 11. Influence of blood collection systems on the prothrombin time and international sensitivity index determined with human and rabbit thromboplastin reagents.
    van den Besselaar AM, Hoekstra MM, Witteveen E, Didden JH, van der Meer FJ.
    Am J Clin Pathol; 2007 May; 127(5):724-9. PubMed ID: 17439830
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.
    Samama MM, Contant G, Spiro TE, Perzborn E, Guinet C, Gourmelin Y, Le Flem L, Rohde G, Martinoli JL, Rivaroxaban Anti-Factor Xa Chromogenic Assay Field Trial Laboratories.
    Thromb Haemost; 2012 Feb; 107(2):379-87. PubMed ID: 22187012
    [Abstract] [Full Text] [Related]

  • 13. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)].
    Sakayori T, Naito S, Yoshida M, Kumano O, Kato N, Okuda M, Ieko M.
    Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170
    [Abstract] [Full Text] [Related]

  • 14. Field study of lyophilized calibrant plasmas for fresh plasma INR determination.
    van den Besselaar AM, Houbouyan-Réveillard LL.
    Thromb Haemost; 2002 Feb; 87(2):277-81. PubMed ID: 11859852
    [Abstract] [Full Text] [Related]

  • 15. Influence of dabigatran and rivaroxaban on routine coagulation assays. A nationwide Belgian survey.
    Van Blerk M, Bailleul E, Chatelain B, Demulder A, Devreese K, Douxfils J, Jochmans K, Mullier F, Wijns W, Soumali MR, Coucke W, Vernelen K, Van de Walle P.
    Thromb Haemost; 2015 Jan; 113(1):154-64. PubMed ID: 25231101
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents.
    Dale BJ, Ginsberg JS, Johnston M, Hirsh J, Weitz JI, Eikelboom JW.
    J Thromb Haemost; 2014 Nov; 12(11):1810-5. PubMed ID: 25196577
    [Abstract] [Full Text] [Related]

  • 17. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K, Fukutake K.
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [Abstract] [Full Text] [Related]

  • 18. Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban.
    Gosselin RC, Adcock D, Hawes EM, Francart SJ, Grant RP, Moll S.
    Thromb Haemost; 2015 Jan; 113(1):77-84. PubMed ID: 25413383
    [Abstract] [Full Text] [Related]

  • 19. International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.
    van den Besselaar AMHP, Chantarangkul V, Angeloni F, Binder NB, Byrne M, Dauer R, Gudmundsdottir BR, Jespersen J, Kitchen S, Legnani C, Lindahl TL, Manning RA, Martinuzzo M, Panes O, Pengo V, Riddell A, Subramanian S, Szederjesi A, Tantanate C, Herbel P, Tripodi A.
    J Thromb Haemost; 2018 Jan; 16(1):142-149. PubMed ID: 29065247
    [Abstract] [Full Text] [Related]

  • 20. Local verification and assignment of mean normal prothrombin time and International Sensitivity Index values across various instruments: recent experience and outcome from North America.
    Tange JI, Grill D, Koch CD, Ybabez RJ, Krekelberg BJ, Fylling KA, Wiese CR, Baumann NA, Block DR, Karon BS, Chen D, Pruthi RK.
    Semin Thromb Hemost; 2014 Feb; 40(1):115-20. PubMed ID: 24381152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.